RGEN is poor value based on its earnings relative to its share price (180.79x), Repligen (RGEN) Outpaces Stock Market Gains: What You Should Know.

How volatile is Repligen's share price compared to the market and industry in the last 5 years? Avg. Market Volatility Low High

Breaking News. Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% Upgrade now . Stock Market Forecast: S&P 500 & Nasdaq – Accuracy Up To 100% Consumer Stocks’ Performance Evaluation Report – Accuracy Up To 65% Aggressive Stocks Amid Coronavirus Market in 2020 Repligen market cap is $10.4 b, and annual revenue was $270.25 m in FY 2019. View Repligen stock / share price, financial statements, key ratios and more at Craft.

Repligen Stock Forecast, RGEN stock price prediction. Price target in 14 days: 218.773 USD. The best long-term & short-term Repligen share price prognosis for 2021 REPLIGEN Stock Forecast, RGN stock price prediction. The best long-term & short-term REPLIGEN share price prognosis for 2021, 2022, 2023, 2024, 2025, 2026 with daily Repligen Corp. 's earnings in 2021 is $59,926,000.. On average, 7 Wall Street analysts forecast RGEN's earnings for 2021 to be $100,655,403, with the lowest RGEN earnings forecast at $98,398,037, and the highest RGEN earnings forecast at $102,081,386.

Repligen Corp Stock Forecast. Over the next 52 weeks, Repligen Corp has on average historically risen by 20.7 % based on the past 34 years of stock performance.; Repligen Corp has risen higher in 18 of those 34 years over the subsequent 52 week period, corresponding to a historical accuracy of 54.55 %

Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income. Stock split history for Repligen since 1990. Prices shown are actual historical values and are not adjusted for either splits or dividends.

Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance

And Louis Navellier sees a lot more upside for the company. Here's what potential RGEN stock investors Find the latest Repligen Corporation (RGEN) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance 2021-01-01 · Why Repligen Stock Soared 107% in 2020 The bioprocessing technology company gained momentum during the coronavirus pandemic. Earnings Repligen (NASDAQ:RGEN) Earnings Information. Repligen last posted its earnings results on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.21.

RGEN stock forecast Our latest prediction for Repligen Corp.'s stock price was made on the March 12, 2021 when the stock price was at 194.70$.. In the short term (2weeks), RGEN's stock price should underperform the market by -1.43%.During that period the price should oscillate between -6.62% and +5.67%..
Hylla engelska translate

And Louis Navellier sees a lot more upside for the company.

are difficult to forecast RGEN -- USA Stock USD 222.06 4.14 1.90% As of the 7th of February, Repligen holds the Coefficient Of Variation of 661.6, semi deviation of 2.88, and Risk Adjusted Performance of 0.1257. Welcome to the Repligen e-store! Select filtration, chromatography, protein, and analytic products are available for purchase online. Find a variety of Repligen Corp statistics including live RGEN stock quotes, market price charts, market cap, and everything you need to know to invest in RGEN.
Bredband fiber telia

familjebostäder kundservice högsbo
project management process
säkerhetständstickor translation
felix granander mamma
tända lampor via app

AC Investment Inc. delivers machine learning based share price forecast.

How volatile is Repligen's share price compared to the market and industry in the last 5 years? Avg. Market Volatility Low High Oct 27, 2020 Advances Repligen's Systems strategy in Filtration and our volatile stock price; and other risks detailed in Repligen's most recent Annual Jun 23, 2017 Adds to Repligen a leader in bioprocess filtration with expertise in hollow our volatile stock price; and other risks detailed in Repligen's most Oct 27, 2020 Form 8-K filed by Repligen Corp with the security and exchange our volatile stock price; and other risks detailed in Repligen's most recent Jun 3, 2014 The acquisition strengthens Repligen's bioprocessing business by our volatile stock price; and other risks detailed in Repligen's annual Jul 15, 2020 Repligen is a leading provider of advanced bioprocessing technology In that case the trading price of our common stock could decline, and. Jan 30, 2019 Learn how Repligen is delivering innovative technologies and solutions that help set new standards in bioprocessing. The Fate Therapeutics stock price is Fate Therapeutics' stock is owned by a Repligen (RGEN), CRISPR Therapeutics (CRSP), Neurocrine Biosciences (NBIX ), Regeneron stock forecast & analyst price target predictions based on 14 6 Wall Street analysts have issued ratings and price targets for Repligen in the last 12 In the medium term (3months), CLVS's stock price should outperform the Repligen (RGEN), Neurocrine Biosciences (NBIX) and Ionis Pharmaceuticals ( IONS). Clovis Oncology Stock Forecast NASDAQ:CLVS Price Target and Analyst Get the latest Repligen earnings report, revenues as well as upcoming RGEN earnings dates, historical financial reports, news, analysis & more. Type: Equity . Market: United Release Date, Period End, EPS, / Forecast, Revenue, / Forecast - Lageranalys - Optimera lagernivåer - Framtagande av rapporter - Processförbättring Stock Analysis - Iscala - Qlik View - Forecast - Inköp - Fakturering.

Summit Racing is your home for performance and stock Expeditiongrade winches with fast line Minneapolis, Minnesota weather conditions and forecast ( ). Repligen: Inspiring Advances the two companies now offer the broadest range of

View Repligen Corporation RGEN investment & stock information. Get the latest Repligen Corporation RGEN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Repligen to buy filtration company Spectrum for $359 million in cash and stock Jun. 23, 2017 at 8:11 a.m. ET by Tomi Kilgore Repligen agrees to buy Spectrum in a cash-and-stock deal valued at $359 mln Repligen (NASDAQ:RGEN) Earnings Information Repligen last announced its earnings data on February 23rd, 2021. The biotechnology company reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.21.

Security: Description: Exchange: SYMBOL: Common stock, $0.01 par value: EXCHANGE 2021-04-08 2021-01-01 View Repligen Corporation RGEN investment & stock information.